The company also reported a 90 percent increase in gross profit, from $45.2 million to $83.5 million, as well as 15 percent decrease in expenses.
More Articles on Orthopedic Devices:
Osseon Therapeutics Names Ron Clough COO
Tibion Introduces Wireless Bionic Leg
Court Tosses Shareholders’ Lawsuit Against Synthes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
